Marine Compounds and Inflammation II
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (15 December 2020) | Viewed by 33929
Special Issue Editors
Interests: marine natural products; structure elucidation; chemical proteomics; target discovery; bioorganic chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Marine metabolites own a unique chemical diversity, containing structural requirements that allow binding to specific targets, and cover a wide range of biological properties that are closely related to their pharmacological potential and therapeutic success in the most diverse diseases. The drug discovery process is moving toward a rationalization in which chemistry and pharmacology converge towards targeted approaches, focused on specific diseases and molecular targets. Inflammation is a defensive response of an organism in which harmful factors, such as pathogens, heat, and cancer cells produce tissue damage. It involves a multitude of cell types, chemical mediators, and interactions. An enormous demand exists for new and potent anti-inflammatory drugs because inflammation underlies a multitude of human diseases, including atherosclerosis, inflammatory bowel diseases, diabetes, rheumatoid arthritis, Alzheimer’s disease, and, in particular, the start and progression of cancer. In this regard, the exploration of marine sources, including sponges, mollusks, algae, and bacteria, in search of potential new leads and drugs for treatment of inflammatory-driven diseases is a strategic goal. As Guest Editors of this Special Issue of Marine Drugs, we invite you to report your findings in the field of marine anti-inflammatory compounds.
Prof. Dr. Agostino Casapullo
Prof. Virginia Motilva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammation
- marine natural products
- marine organisms
- target discovery
- drug discovery
- inflammatory diseases
- anti-inflammatory compounds
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.